These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33498474)

  • 1. LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8.
    Fais M; Sanna G; Galioto M; Nguyen TTD; Trần MUT; Sini P; Carta F; Turrini F; Xiong Y; Dawson TM; Dawson VL; Crosio C; Iaccarino C
    Cells; 2021 Jan; 10(2):. PubMed ID: 33498474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects.
    Ciampelli C; Galleri G; Puggioni S; Fais M; Iannotta L; Galioto M; Becciu M; Greggio E; Bernardoni R; Crosio C; Iaccarino C
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of LRRK2 in the regulation of dopamine receptor trafficking.
    Rassu M; Del Giudice MG; Sanna S; Taymans JM; Morari M; Brugnoli A; Frassineti M; Masala A; Esposito S; Galioto M; Valle C; Carri MT; Biosa A; Greggio E; Crosio C; Iaccarino C
    PLoS One; 2017; 12(6):e0179082. PubMed ID: 28582422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype.
    Rassu M; Biosa A; Galioto M; Fais M; Sini P; Greggio E; Piccoli G; Crosio C; Iaccarino C
    J Cell Mol Med; 2019 Dec; 23(12):8505-8510. PubMed ID: 31560168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Parkinson's Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network.
    Beilina A; Bonet-Ponce L; Kumaran R; Kordich JJ; Ishida M; Mamais A; Kaganovich A; Saez-Atienzar S; Gershlick DC; Roosen DA; Pellegrini L; Malkov V; Fell MJ; Harvey K; Bonifacino JS; Moore DJ; Cookson MR
    Cell Rep; 2020 May; 31(5):107614. PubMed ID: 32375042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A.
    Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S
    J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
    Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
    J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucine-rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre-synaptic sites.
    Marte A; Russo I; Rebosio C; Valente P; Belluzzi E; Pischedda F; Montani C; Lavarello C; Petretto A; Fedele E; Baldelli P; Benfenati F; Piccoli G; Greggio E; Onofri F
    J Neurochem; 2019 Aug; 150(3):264-281. PubMed ID: 31148170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
    Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.
    Trancikova A; Mamais A; Webber PJ; Stafa K; Tsika E; Glauser L; West AB; Bandopadhyay R; Moore DJ
    PLoS One; 2012; 7(10):e47784. PubMed ID: 23082216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25.
    Yun HJ; Park J; Ho DH; Kim H; Kim CH; Oh H; Ga I; Seo H; Chang S; Son I; Seol W
    Exp Mol Med; 2013 Aug; 45(8):e36. PubMed ID: 23949442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 and the Endolysosomal System in Parkinson's Disease.
    Erb ML; Moore DJ
    J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 and membrane trafficking: nexus of Parkinson's disease.
    Hur EM; Jang EH; Jeong GR; Lee BD
    BMB Rep; 2019 Sep; 52(9):533-539. PubMed ID: 31383252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type and mutant (G2019S) leucine-rich repeat kinase 2 (LRRK2) associate with subunits of the translocase of outer mitochondrial membrane (TOM) complex.
    Neethling A; Engelbrecht L; Loos B; Kinnear C; Theart R; Abrahams S; Niesler T; Mellick GD; Williams M; Bardien S
    Exp Cell Res; 2019 Feb; 375(2):72-79. PubMed ID: 30597143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization.
    Migheli R; Del Giudice MG; Spissu Y; Sanna G; Xiong Y; Dawson TM; Dawson VL; Galioto M; Rocchitta G; Biosa A; Serra PA; Carri MT; Crosio C; Iaccarino C
    PLoS One; 2013; 8(10):e77198. PubMed ID: 24167564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network.
    Liu Z; Bryant N; Kumaran R; Beilina A; Abeliovich A; Cookson MR; West AB
    Hum Mol Genet; 2018 Jan; 27(2):385-395. PubMed ID: 29177506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts.
    Kuwahara T; Inoue K; D'Agati VD; Fujimoto T; Eguchi T; Saha S; Wolozin B; Iwatsubo T; Abeliovich A
    Sci Rep; 2016 Jul; 6():29945. PubMed ID: 27424887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.
    Kalogeropulou AF; Zhao J; Bolliger MF; Memou A; Narasimha S; Molitor TP; Wilson WH; Rideout HJ; Nichols RJ
    Biochem J; 2018 Apr; 475(7):1271-1293. PubMed ID: 29519959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.